Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Secreted, extracellular space, extracellular matrix |
Domain |
PF01391 Collagen triple helix repeat (20 copies) |
Function |
Structural component of hyaline cartilage and vitreous of the eye. |
Biological Process |
GO:0001501 skeletal system development GO:0030198 extracellular matrix organization GO:0043062 extracellular structure organization |
Molecular Function |
GO:0005201 extracellular matrix structural constituent GO:0030020 extracellular matrix structural constituent conferring tensile strength |
Cellular Component |
GO:0005578 proteinaceous extracellular matrix GO:0005581 collagen trimer GO:0005593 FACIT collagen trimer GO:0005594 collagen type IX trimer GO:0005788 endoplasmic reticulum lumen |
KEGG |
hsa04151 PI3K-Akt signaling pathway hsa04510 Focal adhesion hsa04512 ECM-receptor interaction hsa04974 Protein digestion and absorption |
Reactome |
R-HSA-2022090: Assembly of collagen fibrils and other multimeric structures R-HSA-422475: Axon guidance R-HSA-1650814: Collagen biosynthesis and modifying enzymes R-HSA-8948216: Collagen chain trimerization R-HSA-1442490: Collagen degradation R-HSA-1474290: Collagen formation R-HSA-1474228: Degradation of the extracellular matrix R-HSA-1266738: Developmental Biology R-HSA-3000178: ECM proteoglycans R-HSA-1474244: Extracellular matrix organization R-HSA-216083: Integrin cell surface interactions R-HSA-375165: NCAM signaling for neurite out-growth R-HSA-419037: NCAM1 interactions R-HSA-162582: Signal Transduction R-HSA-186797: Signaling by PDGF |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between COL9A2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of COL9A2 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of COL9A2 in various data sets.
|
Points in the above scatter plot represent the mutation difference of COL9A2 in various data sets.
|
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of COL9A2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of COL9A2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by COL9A2. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of COL9A2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of COL9A2 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between COL9A2 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | COL9A2 |
Name | collagen, type IX, alpha 2 |
Aliases | EDM2; DJ39G22.4; STL5; alpha 2 type IX collagen; collagen IX, alpha-2 polypeptide; Collagen alpha-2(IX) chai ...... |
Chromosomal Location | 1p33-p32 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting COL9A2 collected from DrugBank database. |
There is no record. |